Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0489
Source ID: NCT00190580
Associated Drug: Valsartan
Title: Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|Hypertension
Interventions: DRUG: valsartan|DRUG: Conventional antihypertensive drugs
Outcome Measures: Primary: Course of renal and cardiac function, every month for renal function and every year for cardiac function | Secondary: Doubling of serum creatinine concentration, every month|End-stage renal disease, anytime when it occurs.|Myocardial infarction, anytime when it occurs.|Coronary revascularization, anytime when it occurs.|Stroke, anytime when it occurs|Hospitalization for unstable angina, anytime when it occurs.|Hospitalization for heart failure, anytime when it occurs.|Death from cardiovascular causes, anytime when it occurs.
Sponsor/Collaborators: Sponsor: KVT-Study Group | Collaborators: Tokai University|Yokohama City University|Showa University|Kitasato University|St. Marianna University School of Medicine
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 312
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2003-02
Completion Date: 2008-04
Results First Posted:
Last Update Posted: 2015-03-31
Locations: St. Marianna University School of Medicine, Kawasaki, Kanagawa, 216-8511, Japan
URL: https://clinicaltrials.gov/show/NCT00190580